Steven Nissen (born September 1, 1948) is a board-certified American cardiologist in Cleveland, Ohio. He is a researcher and patient advocate who served as the chairman of cardiovascular medicine at the Cleveland Clinic, in Cleveland, Ohio.
Steven Nissen Facts
- Full Name: Steven E. Nissen
- Age: 74 years old
- Date of Birth: September 1, 1948
- Place of Birth: Toledo, Ohio
- Occupation: Cardiologist
- Nationality: American
- Wife: Linda Butler
Steven Nissen Medical School & Residency
- University Of Kentucky Hospital, Fellowship Hospital
- Univ Of California Davis Medical Center, Residency Hospital
- Univ Of California Davis Medical Center, Internship Hospital
- UNIVERSITY OF MICHIGAN / MEDICAL CENTER, Medical School — 1978
Steven Nissen Career
Steven E. Nissen was the head of the department of cardiovascular medicine at the Cleveland Clinic and a former president of the American College of Cardiology, the organization that represents American cardiologists.
His research has centered on intravascular ultrasonography, an imaging technology that measures the accumulation of plaque in the coronary arteries using microscopic probes. Additionally, he has published extensively on drug safety. In 2001, he co-authored the first publication that presented safety concerns regarding Vioxx, which was pulled from the market three years later.
In 2007, he discovered that the widely prescribed diabetic medication Avandia increased the risk of heart attack, prompting the Food and Drug Administration to issue a warning six months later. In 2007, Time magazine ranked Dr. Nissen among the “100 most influential individuals in the world.”
Certifications & Licensure
- American Board of Internal Medicine – Certified in Cardiovascular Disease
- American Board of Internal Medicine – Certified in Internal Medicine
- CA State Medical License
- OH State Medical License – Active through 2024
Cleveland Clinic, Cleveland, OH
Steven Nissen has the following 32 areas of expertise
- Coronary Artery Angioplasty & Stent
- Heart Attack
- Pathologic Constriction
- Cardiovascular Disease
- Heart Transplantation
- Blood Clot
- Coronary Angiography
- Pulmonary Hypertension
- Heart Diseases
- Myocardial Infarction
- Metabolic Syndrome X
- Coronary Disease
- Coronary Atherectomy
- Arteriosclerosis (Arterial Disease)
- Diabetes, Type 2
- Unstable Angina
- Chest Pain (Angina)
- Heart Catheterization
- Heart Block
- Acute Coronary Syndrome (ACS)
- High Cholesterol
- Coronary Artery Disease (CAD)
- Transesophageal Echocardiography
- Coronary Stenosis
- Heart Failure
- Heart Disease (Myocardial Ischemia)
- Aetna Choice POS II
- Aetna Health Network Option Open Access
- Aetna HMO
- Aetna Managed Choice POS Open Access
- Aetna Signature Administrators PPO
- Anthem Blue Access PPO
- Anthem Blue Preferred HMO
- BCBS Blue Card PPO
- BCBS IL PPO
- BCBS MI PPO Plans Group Enrollees
- CIGNA HMO
- CIGNA Open Access Plus
- CIGNA PPO
- First Health PPO
- Humana Choice POS
- Humana ChoiceCare Network PPO
- Medmutual OhioHealth Network MRF
- MMOH SuperMed POS Select
- MMOH SuperMed PPO Plus
- Multiplan PPO
- UHC Choice Plus POS
- UHC Navigate HMO
- UHC Navigate POS
- UHC Options PPO
Location & Contact Information
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland , OH 44195
Data provided by the National Library of Medicine
- Impact of intravascular ultrasound in understanding transplant coronary artery disease.
- The current status of intravascular ultrasound imaging.
- Shortcomings of coronary angiography and their implications in clinical practice.
- Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study.
- Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes.
- Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging.
- Comparison of troponin T versus creatine kinase-MB in suspected acute coronary
- American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase I: The effect of lossy data compression on recognition of diagnostic features in digital coronary angiography.
- American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase III: measurement of image quality differences at varying levels of data compression.
- Three-dimensional reconstruction of the coronary artery wall by image fusion of intravascular ultrasound and bi-plane angiography.
- Assessment of coronary compensatory enlargement by three-dimensional intravascular ultrasound.
- Rationale for a postintervention continuum of care: insights from intravascular ultrasound.
- The vulnerable coronary plaque.
Steven Nissen Net Worth
Steven Nissen had an estimated net worth of $6 million.